Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
- Previous Close
226.01 - Open
227.95 - Bid 223.65 x --
- Ask 223.66 x --
- Day's Range
222.84 - 227.87 - 52 Week Range
206.80 - 351.60 - Volume
5,159,607 - Avg. Volume
6,035,549 - Market Cap (intraday)
271.247B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
24.34 - EPS (TTM)
9.19 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 11.51 (5.14%)
- Ex-Dividend Date Nov 7, 2024
- 1y Target Est
306.68
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
www.mindray.comRecent News: 300760.SZ
View MorePerformance Overview: 300760.SZ
Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300760.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300760.SZ
View MoreValuation Measures
Market Cap
271.25B
Enterprise Value
253.84B
Trailing P/E
24.33
Forward P/E
22.08
PEG Ratio (5yr expected)
0.79
Price/Sales (ttm)
7.61
Price/Book (mrq)
7.03
Enterprise Value/Revenue
7.13
Enterprise Value/EBITDA
20.28
Financial Highlights
Profitability and Income Statement
Profit Margin
31.29%
Return on Assets (ttm)
13.55%
Return on Equity (ttm)
28.18%
Revenue (ttm)
35.59B
Net Income Avi to Common (ttm)
11.14B
Diluted EPS (ttm)
9.19
Balance Sheet and Cash Flow
Total Cash (mrq)
17.71B
Total Debt/Equity (mrq)
0.69%
Levered Free Cash Flow (ttm)
5.35B